Last week's Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs and Health did a grave disservice to Americans rightfully upset about the rising tide of drug and alcohol dependency in their communities.
When Republicans attempt to repeal and replace the ACA, they may have to change course on repeal if they want insurers on board with replace.
The first of the U.S. Justice Department's highly anticipated healthcare merger challenges is set to start next week in Washington, D.C.,as Anthem and Cigna Corp. defend their proposed merger.
Major changes in the exchange-based individual market will spill over to Americans with practically any type of health coverage—Medicare, Medicaid or employer-based plans.
Medigap insurers and hospitals that enter preferred-network arrangements could run the risk of violating federal anti-kickback laws, but an HHS watchdog said it wouldn't fine those organizations due to low fraud risk.
Blue Cross and Blue Shield of North Carolina blasted the federal government on Monday for trying to dodge hundreds of millions of dollars in overdue risk-corridor payments, alleging the feds' defenses are nothing more than “revisionist history.”
Healthcare pricing concerns are making a late run for relevance as the presidential campaign heads down the homestretch. Unfortunately, too much attention is being paid to price hikes on the Obamacare exchanges, which affect only a thin sliver of the population.
Dale Maxwell will become interim CEO at Albuquerque-based Presbyterian Healthcare Services when current president and CEO James Hinton leaves to become chief executive at Dallas-based Baylor Scott & White Health in January 2017.
Sen. Bernie Sanders, who defeated Hillary Clinton by nearly 19 points in the state's Democratic caucus, has endorsed and campaigned for the measure. But a September poll suggested just 27% of voters were likely to support it.
The nearly 400,000 people who buy their own health insurance in Michigan will see premiums rise by an average of 16.7% next year, a sticker shock that insurers and the government say can be offset for those who qualify for tax credits.
The Medicare Access and CHIP Reauthorization Act final rule released earlier this month includes funding to create and implement a core set of performance measures to be used by private and public insurers alike.
Two top lawmakers on Thursday demanded information from a drug company that has raised prices on a leukemia drug, calling increases of tens of thousands of dollars a sign the company puts profits before patients.